Volcano to Present Clinical Trial Results, FFR Product Launch at TCT 2011

 

November 9, 2011

The PrimeWire Prestige Plus is a new fractional flow reserve (FFR) catheter from Volcano Corp. It is the third pressure guidewire the company has introduced in the last three years.

Volcano is expanding its functional management offerings to include an investigational product called instant wave-free ratio or iFR. The company is collaborating with physicians at Imperial College and Hospital Clinico San Carlos to develop a technology with the objective of achieving FFR-like measurements without the use of adenosine. The compound in question is a vasodilator injected to achieve maximum coronary flow, which can increase time, cost and complexity of the procedure, and cause patient discomfort.

iFR is designed to provide a pharmaceutical-free means of assessing the functional performance of a discrete lesion as a measure of FFR.

In an effort to make the benefits of FFR accessible to more clinicians and patients, Volcano is working with suppliers of hemodynamic monitoring systems to provide FFR on their systems. The Smart Map Pressure Instrument is now compatible with the FFR module of the Philips Xper Flex Cardio Physiomonitoring System. This complements Volcano's current compatibility with GE Healthcare's Mac-Lab XT and XTi hemodynamic recording systems version 6.8.1; Siemens' Axiom Sensis XP VC11; McKesson's Horizon Cardiology Hemo version 12.1; and Mennen's Horizon XVu Hemodynamic Monitoring System.

The PrimeWire Prestige Plus was introduced at the 2011 Transcather Cardiovascular Therapeutics (TCT) meeting.

For more information: www.volcanocorp.com

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.